What laboratory tests should be ordered to evaluate chronic hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Laboratory Workup for Chronic Hyponatremia

When evaluating chronic hyponatremia (serum sodium <135 mEq/L), order serum osmolality, urine osmolality, urine sodium, urine electrolytes, and serum uric acid; assess volume status clinically and consider central venous pressure (CVP) measurement when available to distinguish between SIADH and cerebral salt wasting. 1

Essential Laboratory Tests

The diagnostic workup should be triggered when serum sodium falls below 131 mmol/L and must include 1:

  • Serum osmolality - to confirm true hypotonic hyponatremia (excludes pseudohyponatremia from hyperglycemia or hypertriglyceridemia)
  • Urine osmolality - inappropriately high (>300-500 mosm/kg) suggests SIADH 2
  • Urine sodium concentration - critical for differential diagnosis
  • Urine electrolytes - complete panel
  • Serum uric acid - levels <4 mg/dL have 73-100% positive predictive value for SIADH 1

Additional Required Tests

To exclude other causes before diagnosing SIADH 1:

  • Thyroid function (TSH) - rule out hypothyroidism
  • Cortisol/ACTH - exclude adrenal insufficiency
  • Blood urea nitrogen (BUN) and creatinine - assess renal function
  • Liver function tests - rule out cirrhosis in hypervolemic cases

Interpreting Urine Sodium

The urine sodium concentration guides volume status assessment 1:

  • Urine Na <30 mmol/L: 71-100% positive predictive value for saline responsiveness (suggests hypovolemia)
  • Urine Na >40 mmol/L: suggests SIADH or cerebral salt wasting
  • Fractional excretion of sodium and urea: low values associated with saline responsiveness 1

Volume Status Assessment

Physical examination alone is inadequate (sensitivity only 41.1%, specificity 80%) for determining volume status 1. The guidelines emphasize:

Clinical Parameters to Document:

  • Mucosal hydration
  • Skin turgor
  • Jugular venous distention
  • Orthostatic vital signs (pulse increase >10%, systolic BP decrease >10%)

Invasive Monitoring When Available 1:

  • CVP <5 cm H₂O: hypovolemic (cerebral salt wasting)
  • CVP 6-10 cm H₂O: normovolemic (SIADH)
  • CVP >10 cm H₂O: hypervolemic (heart failure, cirrhosis)

Studies show CVP-guided treatment corrected sodium within 72 hours in 73% of patients 1.

Tests NOT Recommended

Do not routinely order 1:

  • ADH levels - limited diagnostic value; "appropriateness" undefined, and SIADH documented even with undetectable ADH
  • Natriuretic peptides - conflicting data, not supported by evidence

Diagnostic Algorithm Structure

  1. Confirm true hyponatremia: Check serum osmolality

    • Low (<275 mosm/kg): proceed with workup
    • Normal/high: pseudohyponatremia or hyperglycemia

  2. Categorize by volume status: Clinical exam + CVP if available

    • Hypovolemic (CVP <5): Check urine Na

      • Urine Na <30: extrarenal losses
      • Urine Na >40: renal losses (diuretics, cerebral salt wasting, adrenal insufficiency)

    • Euvolemic (CVP 6-10): Rule out hypothyroidism, adrenal insufficiency, polydipsia

      • If excluded → SIADH (requires urine osm >300, urine Na >40, uric acid <4)

    • Hypervolemic (CVP >10): Evaluate for heart failure, cirrhosis, renal failure

Critical Pitfalls to Avoid

  • Do not rely on physical exam alone for volume assessment - it misses hypovolemia in >50% of cases 1
  • Do not delay treatment while pursuing diagnostic workup in symptomatic patients 3
  • Do not order ADH levels - they add no diagnostic value and delay appropriate management 1
  • Always exclude diuretic use before diagnosing SIADH or cerebral salt wasting 1
  • Check for infection - hyponatremia may signal acute inflammation; perform diagnostic paracentesis in cirrhotic patients 4

Context-Specific Considerations

In neurosurgical patients: Chronic hyponatremia (>48 hours) with mean sodium 115-122 mmol/L carries significant morbidity risk. In subarachnoid hemorrhage specifically, hyponatremia increases cerebral ischemia rates (odds ratio 2.7 for poor outcomes) 1.

In cirrhotic patients: Document daily sodium/fluid intake, alcohol use, medications (diuretics, laxatives), and assess for infection. Hyponatremia reflects worsening hemodynamics and increases risk of hepatic encephalopathy (OR 3.4), hepatorenal syndrome (OR 3.5), and spontaneous bacterial peritonitis (OR 2.4) 5, 4.

References

Related Questions

How should I evaluate and manage a patient with hyponatremia?
What is the appropriate evaluation and management for a patient with serum sodium 133 mmol/L (mild hyponatremia) and glucose 107 mg/dL?
In a patient with a serum sodium of 117 mmol/L and minimal symptoms, what is the appropriate management?
How should hyponatremia with a serum sodium of 130 mmol/L and hypochloremia with a serum chloride of 93 mmol/L be managed?
How should I manage a patient with hyponatremia (serum sodium 133 mmol/L) and a serum albumin of 4.7 g/dL?
Why was my post‑prandial blood glucose 72 mg/dL after drinking orange juice when I am a non‑diabetic adult who normally does not have values in the 70s?
What folic acid dose should be prescribed for a patient on weekly methotrexate, and for women of child‑bearing potential planning pregnancy?
Can excessive B‑complex supplementation, especially high‑dose pyridoxine (vitamin B6), worsen peripheral neuropathy?
What is the appropriate workup and management for a suspicious nodular thickening of the left adrenal gland?
What is the recommended duration of dual antiplatelet therapy after a non‑cardioembolic ischemic stroke?
What are the therapeutic uses and benefits of S‑acetyl L‑glutathione in humans?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.